Meeting
2022 ASCO Annual Meeting
Treatment patterns and real-world effectiveness of rituximab maintenance in older patients with mantle cell lymphoma: A population-based analyses.
Authors
Mengyang Di
Yale University School of Medicine, New Haven, CT
Mengyang Di , Jessica B. Long , Shalin Kothari , Tarsheen Kaur Sethi , Amer Methqal Zeidan , Nikolai Alexandrovich Podoltsev , Rory Shallis , Rong Wang , Xiaomei Ma , Scott F. Huntington
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Track
Hematologic Malignancies
Sub Track
Non-Hodgkin Lymphoma
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 7554)
DOI
10.1200/JCO.2022.40.16_suppl.7554
Abstract #
7554
Poster Bd #
207
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Quality Care Symposium
Real-world treatment (tx) patterns, cost, and overall survival (OS) by line of therapy among patients (pt) with mantle cell lymphoma (MCL): A SEER-Medicare (SM) analysis.
First Author: Scott J. Keating
Poster
2013 ASCO Annual Meeting
Efficacy of radioimmunotherapy-based conditioning with high-dose chemotherapy and autologous stem cell transplantation for transformed lymphoma.
First Author: Amrita Y. Krishnan
Poster
2023 ASCO Annual Meeting
Subgroup analysis of elderly patients (pts) with diffuse large B-cell lymphoma (DLBCL) in the phase 3 POLARIX study.
First Author: Bei Hu
Poster
2023 ASCO Annual Meeting
Phase II trial of split-dose R-CHOP for older patients with diffuse large B-cell lymphoma (DLBCL).
First Author: Nirav Niranjan Shah